Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Neurophysiological Correlates of Central Fatigue in Healthy Subjects and Multiple Sclerosis Patients before and after Treatment with Amantadine.
[Vitamin D in Multiple Sclerosis].
Macrophage Migration Inhibitory Factor Potentiates Autoimmune-Mediated Neuroinflammation.
Effects of pregnancy and breastfeeding on the multiple sclerosis disease course.
Whole-body in vivo monitoring of inflammatory diseases exploiting human interleukin 6-luciferase transgenic mice.
Registers of multiple sclerosis in Denmark.
Phonological fluency strategy of switching differentiates relapsing-remitting and secondary progressive multiple sclerosis patients.
Brain atrophy in natalizumab-treated patients: A 3-year follow-up.
Rapid parametric mapping of the longitudinal relaxation time t1 using two-dimensional variable flip angle magnetic resonance imaging at 1.5 tesla, 3 tesla, and 7 tesla.
Two decades of subcutaneous glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing-remitting multiple sclerosis treatment.
Elevated Expression of Fractalkine (CX3CL1) and Fractalkine Receptor (CX3CR1) in the Dorsal Root Ganglia and Spinal Cord in Experimental Autoimmune Encephalomyelitis: Implications in Multiple Sclerosis-Induced Neuropathic Pain.
Smoking as a risk factor for development of Secondary Progressive Multiple Sclerosis: A study in IRAN, Guilan.
Multiple sclerosis: Spinal cord MRI reveals progression-related MS pathology.
Long-term results from a phase 2 extension study of fingolimod at high and approved dose in relapsing multiple sclerosis.
Combinations of susceptibility genes are associated with higher risk for multiple sclerosis and imply disease course specificity.
mTORC1 signaling and IL-17 expression: Defining pathways and possible therapeutic targets.
HDAC1/2-Dependent P0 Expression Maintains Paranodal and Nodal Integrity Independently of Myelin Stability through Interactions with Neurofascins.
Review of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA(®)) for Pseudobulbar Affect.
[Diagnosis and treatment of neuromyelitis optica.]
Open Ring Sign Diagnostic of Multiple Sclerosis in the Emergency Department.
[Therapeutic plasma exchange: applications in neurology].
Multiple sclerosis: Cannabis use is associated with deleterious brain changes in patients with multiple sclerosis.
Polymorphism of the osteopontin gene and clinical course of multiple sclerosis in the Polish population.
Increasing the Contrast of the Brain MR FLAIR Images Using Fuzzy Membership Functions and Structural Similarity Indices in Order to Segment MS Lesions.
Development of a short form and scoring algorithm from the validated actionable bladder symptom screening tool.
Pages
« first
‹ previous
…
429
430
431
432
433
434
435
436
437
…
next ›
last »